Addex Therapeutics (0QNV) Revenue
Addex Therapeutics Revenue
Addex Therapeutics had a revenue of 9.95K in the quarter ending Jun 30, 2026, with 29.35%. This bring the company's revenue in the last twelve months to 63.19K, Decreased 29.49%. In the fiscal year ending Mar 31, 2026, Addex Therapeutics had annual revenue of 173.00K with -57.81% growth.
- Revenue (ttm)
- 63.19K
- Revenue Growth
- -50.34%
- P/S Ratio
- 16.20
- Revenue/Employee
- CHF 57,667
- Employees
- 3
- Market Cap
- CHF 2.80M
Revenue Chart
Addex Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 173.00K | -237.04K | -57.81% |
| Mar 31, 2025 | 410.04K | -1.20M | -74.58% |
| Mar 31, 2024 | 1.61M | 190.51K | 13.39% |
| Dec 31, 2022 | 1.42M | -1.49M | -51.22% |
| Dec 31, 2021 | 2.92M | -696.51K | -19.28% |
| Dec 31, 2020 | 3.61M | 849.99K | 30.77% |
| Mar 31, 2020 | 2.76M | -3.28M | -54.29% |
| Dec 31, 2018 | 6.04M | 5.54M | 1109.03% |
| Dec 31, 2017 | 499.89K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| GB:0QNV | 63.19K |